[
    [
        {
            "time": "",
            "original_text": "国盛证券药行业2019年中期策略：细分真英雄方主沉浮",
            "features": {
                "keywords": [
                    "国盛证券",
                    "药行业",
                    "2019年",
                    "中期策略",
                    "细分",
                    "英雄",
                    "沉浮"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国盛证券药行业2019年中期策略：细分真英雄方主沉浮",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "【国盛医药张金洋团队】医药行业2019年中期策略：结构优化看百家争鸣，细分真英雄方主沉浮",
            "features": {
                "keywords": [
                    "国盛医药",
                    "张金洋",
                    "团队",
                    "医药行业",
                    "2019年",
                    "中期策略",
                    "结构优化",
                    "百家争鸣",
                    "细分",
                    "英雄",
                    "沉浮"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【国盛医药张金洋团队】医药行业2019年中期策略：结构优化看百家争鸣，细分真英雄方主沉浮",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "【医药行业】2019年中期策略：结构优化看百家争鸣，细分真英雄方主沉浮----寻找行业结构优化进程中高景气成长细分的确定性",
            "features": {
                "keywords": [
                    "医药行业",
                    "2019年",
                    "中期策略",
                    "结构优化",
                    "百家争鸣",
                    "细分",
                    "英雄",
                    "沉浮",
                    "高景气",
                    "成长",
                    "确定性"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【医药行业】2019年中期策略：结构优化看百家争鸣，细分真英雄方主沉浮----寻找行业结构优化进程中高景气成长细分的确定性",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "财经早报: MSCI纳A权重翻倍 美股暴跌道指重挫617点 连续下跌",
            "features": {
                "keywords": [
                    "财经早报",
                    "MSCI",
                    "纳A",
                    "权重翻倍",
                    "美股",
                    "暴跌",
                    "道指",
                    "重挫617点",
                    "连续下跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "全球市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "财经早报: MSCI纳A权重翻倍 美股暴跌道指重挫617点 连续下跌",
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]